By  on June 24, 2019

The mainstreaming of CBD beauty products like lip balm, face serums and soaps containing the hemp extract cannabidiol has seen great demand from consumers, but little oversight from governing bodies.  

The 2018 Farm Bill in December, which removed hemp from the list of drugs under the Controlled Substances Act, set the stage for the widespread commercialization of hemp-derived products, but it left a lot unknown. Then last month, the U.S. Patent and Trademark Office joined the fray. As applications rolled in to trademark CBD products, the agency issued guidance saying that marks can qualify for federal trademark protection if they are legally used in commerce. But it isn’t just about the Controlled Substances Act, the office said —  it also means that the Food and Drug Administration, which implements the Food, Drug and Cosmetic Act, might need to provide some answers. 

To continue reading this article...

load comments
blog comments powered by Disqus